MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Mitochondrial morphometrics in idiopathic Parkinson‘s disease fibroblasts

    P. Antony, O. Boyd, K. Mommaerts, K. Sokolowska, M. Ostaszewski, A. Baumuratov, L. Longhino, F. Poulain, R. Krueger, R. Balling, N. Diederich (Belvaux, Luxembourg)

    Objective: To identify mitochondrial morphometric phenotypes in fibroblasts derived from patients with idiopathic Parkinson’s disease (IPD). Background: Mitochondrial dysfunction (MD) has been proposed as cellular…
  • 2018 International Congress

    Primary familial brain calcification – The impact of calcifications on the development of motor symptoms

    D. Alvarez-Fischer, C. Schiemenz, G. Mahlke, A. Keller, A. Westenberger, J. Erdmann, Z. Aherrahrou, C. Klein (Lübeck, Germany)

    Objective: The aim of the present study was to investigate whether the nigro-striatal system in a genetic mouse model of primary familial brain calcification (PFBC)…
  • 2018 International Congress

    High amplitude jerky tremor in developmental dopamine deficiency

    S. Galosi, M.R. Pons, B. Zouvelou, V. Leuzzi, J. Friedman (Rome, Italy)

    Objective: To describe the phenomenology of tremor in infantile parkinsonism due to dopamine deficiency. Background: Parkinsonism in childhood is usually caused by genetic abnormality, including…
  • 2018 International Congress

    Diagnostic tips from a case series of patients with Late Onset Tay Sachs disease

    G.M. Riboldi, K. Anstett, H. Lau (New York, NY, USA)

    Objective: To describe a population of eight patients with Late Onset Tay Sachs (LOTS) disease and offer tips to aid in diagnosing this rare condition.…
  • 2018 International Congress

    Chitotriosidase is a biomarker for Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)

    S. Hayer, J. Böhringer, L. Schöls (Tübingen, Germany)

    Objective: ALSP belongs to the large group of rare neurogenetic, adult-onset leukodystrophies. For most of these leukodystrophies, including ALSP, no causative treatment exists. Biomarkers facilitate…
  • 2018 International Congress

    Deep brain stimulation: A Treatment Modality for Generalized Dystonia Secondary to Anoxic Brain Injury in Adults

    P. Vittal, J. Rosenow, M. Nolt, J. Pallone, M. McGraw, A. Monette, L. Guzman, A. Shrivastava, M. Mercury, M. Rezak (Winfield, IL, USA)

    Objective: To report a case of severe generalized dystonia secondary to anoxic brain injury treated successfully with bilateral globus pallidus interna (GPi) deep brain stimulation…
  • 2018 International Congress

    Predictor for speech deterioration following STN-DBS in PD patients

    Y. Tanaka, T. Tsuboi, H. Watanabe, D. Nakatsubo, S. Maesawa, S. Kato, Y. Kajita, M. Sato, R. Odake, M. Hattori, M. Yamamoto, T. Wakabayashi, M. Katsuno, G. Sobue (Nagoya, Japan)

    Objective: We conducted a 2-year prospective study of PD patients treated with subthalamic nucleus deep brain stimulation (STN-DBS) to elucidate the predictive factors of deterioration…
  • 2018 International Congress

    Subthalamic neuromodulation restores motor learning in Parkinson’s disease

    A.L. Marcelino, A. Horn, A. Kühn, W.J. Neumann (Berlin, Germany)

    Objective: The aims of the present study were to (i) investigate the effect of subthalamic deep brain stimulation (STN-DBS) on motor learning in Parkinson’s disease…
  • 2018 International Congress

    Attitudes toward earlier use of deep brain stimulation among patients with Parkinson’s disease

    L. Cabrera, C. Sidiropoulos (East Lansing, MI, USA)

    Objective: To explore Parkinson’s patient experiences with Deep Brain Stimulation (DBS) and attitudes towards earlier use of DBS. Background: In November 2015 the U.S. Food…
  • 2018 International Congress

    The effects of deep brain stimulation of the pedunculopontine nucleus on cognition in Parkinson’s disease and Progressive Supranuclear Palsy

    F. Leimbach, J. Gratwicke, T. Foltynie, M. Hariz, P. Limousin, L. Zrinzo, M. Jahanshahi (London, United Kingdom)

    Objective: To investigate the effects of deep brain stimulation (DBS) of the pedunculopontine nucleus (PPN) on different cognitive domains for Parkinson’s disease (PD) and progressive…
  • « Previous Page
  • 1
  • …
  • 55
  • 56
  • 57
  • 58
  • 59
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley